Procter & Gamble Co has announced an agreement to sell its Hipoglos diaper rash cream brand in Brazil to Johnson & Johnson Consumer Inc. The terms of the deal weren’t disclosed, although it is expected to clear in under 6 months.
In his first comments since taking over Procter & Gamble last November, Chief Executive David Taylor laid out the challenges and strategic missteps he is working to overcome at the world’s biggest consumer-products company.
Mr. Taylor’s goal of returning P&G to growth rests on cutting $10 billion over the next five years, in addition to a $10 billion cost-cutting plan implemented in 2012. The cuts will be broad and include everything from marketing to supply chain.
Full Content: Nasdaq
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Competition Office to Scrutinize High Electricity Prices in Germany
Jan 2, 2025 by
CPI
Mexican Lawmakers Advance Controversial Plan to Dissolve Independent Oversight Bodies
Jan 2, 2025 by
CPI
Motorola Accuses UK of Antitrust Breach Over Terminated Emergency Services Contract
Jan 2, 2025 by
CPI
Amazon Must Face Antitrust Case Over Alleged Monopoly Practices
Jan 2, 2025 by
CPI
US Appeals Court Blocks FCC’s Move to Reinstate Net Neutrality Rules
Jan 2, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand